Eating Disorders Trial, Recruiting NCT07037017 Sponsor: Istanbul Nisantasi University Condition: Eating Disorders
Back to Eating Disorders

Eating Disorders Trial, Recruiting

NCT07037017
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman between 18 and 35 years old
  • You have been diagnosed with restrictive-type anorexia nervosa according to standard medical guidelines (DSM-5)
  • Your Body Mass Index (BMI) is between 15.0 and 18.5 (a measure of body weight relative to height)
  • Your doctor considers you physically stable enough to take part in psychological and brain-related assessments
  • You are willing to attend weekly therapy sessions (if placed in the therapy group) and complete assessments at the start and end of the trial
  • You are able to give your own informed agreement to take part in the study

Who may not be able to join:

  • You have ever been diagnosed with bulimia nervosa, binge-eating disorder, or any other eating disorder
  • You currently have a serious mental health condition such as psychosis, bipolar disorder, or a substance use disorder
  • You have a history of a neurological illness or a brain injury caused by trauma
  • You have taken psychiatric medications in the last 6 weeks
  • You have previously taken part in a structured Cognitive-Behavioral Therapy (CBT) programme specifically for an eating disorder
  • You are currently pregnant
  • You have vision or neurological difficulties that would interfere with brain and body measurement recordings (such as EEG, skin response, or eye-tracking tests) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gökben Hızlı Sayar, Professor, Üsküdar University

Phone: 00905324732070

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istanbul Nisantasi University
Registry
ClinicalTrials.gov
Start date
15 May 2025
Est. completion
15 September 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Change in EEG P300 amplitude in response to body image stimuli; Change in Late Positive Potential (LPP) amplitude to body and food stimuli; Change in frontal alpha asymmetry during self-image viewing; Change in skin conductance response (SCR) to body and food stimuli; Change in fixation duration on weight-related body areas

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov